Our findings suggest that CDKN2B‐AS1 levels and its polymorphic variants at rs564398 and rs1537373 may influence the clinicopathological development and progression of HCC in a Taiwanese population. The gene discussed is CDKN2B; the disease is hepatocellular carcinoma.